4-Benzyl-2-(2-(dimethylamino)ethyl)phthalazin-1(2H)-one

Catalog No.: 
ACQXKO849
CAS No.: 
16188-61-7
Molecular Formula: 
C19H21N3O
Molecular Weight: 
307.40
4-Benzyl-2-(2-(dimethylamino)ethyl)phthalazin-1(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg95%$86.00InquiryInquiry
5mg95%$207.00InquiryInquiry
10mg95%$307.00InquiryInquiry
25mg95%$522.00InquiryInquiry
50mg95%$753.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Benzyl-2-(2-(dimethylamino)ethyl)phthalazin-1(2H)-one
IUPAC Name4-benzyl-2-(2-(dimethylamino)ethyl)phthalazin-1(2H)-one
Molecular FormulaC19H21N3O
Molecular Weight307.40
SMILESO=C1N(CCN(C)C)N=C(CC2=CC=CC=C2)C3=C1C=CC=C3
InChI KeyLCAAMXMULMCKLJ-UHFFFAOYSA-N
SynonymTalastine;4-Benzyl-2-[2-(dimethylamino)ethyl]phthalazin-1(2H)-one;4-benzyl-2-[2-(dimethylamino)ethyl]phthalazin-1-one;1(2H)-Phthalazinone, 2-[2-(dimethylamino)ethyl]-4-(phenylmethyl)-
CAS No.16188-61-7

Synthetic Route by SureRoute

1. ACQXKO849 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEOXT642 route compound structure diagram
    ACEOXT64232003-14-8In Stock
  4. Then
  5. ACQXKO849 route product structure diagram
    ACQXKO84916188-61-7
Inquiry

2. ACQXKO849 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQXKO849 route product structure diagram
    ACQXKO84916188-61-7
Inquiry

3. ACQXKO849 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQXKO849 route product structure diagram
    ACQXKO84916188-61-7
Inquiry

Comments (0)